glp-1 receptor agonists alternatives to ozempic Is the Same as Ozempic? Understanding Key Differences Trends in Glucagon-Like Peptide 1

doi: 10.1161/HYPERTENSIONAHA.120.16876 46 UijlEMirabito ColafellaKMSunYRenLvan VeghelRGarreldsIMet al

Tirzepatide significantly reduced food intake and body weight

Start with a low dose and increase gradually

Systematic review of cardiovascular outcome trials with meta-analysis

In one study, microdosing GLP-1s supported moderate weight loss of up to 10 pounds over 40 weeks in participants. MICRODOSING GLP-1 BENEFITS Do More, Age Less Modulated inflammatory pathways in clinical trials. Studies found a reduced risk of cognitive decline Supported cardiovascular health in clinical trials Improved mitochondrial function and oxidative stress in clinical trials Low doses reduced side effects in clinical trials Supported moderate weight loss of up to 10 pounds over 40 weeks in one study *See studies cited below

They advocate routine preoperative gastric ultrasonography and recommend anesthetic management strategies, including airway protection, rapid sequence intubation, and general anesthesia